Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinsuke Yasuda

Showing results (141-150 of 153) with videos related to

Pageof 16
Sort By:
Japanese Journal of Infectious Diseases|June 1, 2022
Association of SARS-CoV-2 RNA Copy Number with the COVID-19 Mortality Rate and Its Effect on the Predictive Performance of Mortality in Severe CasesTakahiro Mitsumura, Tsukasa Okamoto, Mizuho Tosaka, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 19, 2023
Safety and Efficacy of Long-Term Voclosporin Treatment for Lupus Nephritis in the Phase 3 AURORA 2 Clinical TrialAmit Saxena, Ellen M Ginzler, Keisha Gibson, et al.
Modern Rheumatology|December 11, 2013
A comparison of incidence and risk factors for serious adverse events in rheumatoid arthritis patients with etanercept or adalimumab in Korea and JapanSoo-Kyung Cho, Ryoko Sakai, Toshihiro Nanki, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2014
Autoantibodies to IgG/HLA class II complexes are associated with rheumatoid arthritis susceptibilityHui Jin, Noriko Arase, Kouyuki Hirayasu, et al.
Modern Rheumatology|August 22, 2020
Efficacy and safety of sodium RISedronate for glucocorticoid-induced OsTeoporosis with rheumaTOid arthritis (RISOTTO study): A multicentre, double-blind, randomized, placebo-controlled trialYuichiro Fujieda, Tetsuya Horita, Naoki Nishimoto, et al.
Arthritis Research & Therapy|April 17, 2015
Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registryRyoko Sakai, Soo-Kyung Cho, Toshihiro Nanki, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2026
LRBA organizes distinct vesicular trafficking systems in distal nephron segments for water and sodium conservationKanako Nagaoka, Fumiaki Ando, Tamami Fujiki, et al.
The Journal of Rheumatology|February 3, 2015
Assessment of risks of pulmonary infection during 12 months following immunosuppressive treatment for active connective tissue diseases: a large-scale prospective cohort studyHayato Yamazaki, Ryoko Sakai, Ryuji Koike, et al.
Immunity|July 13, 2023
Expression of the readthrough transcript CiDRE in alveolar macrophages boosts SARS-CoV-2 susceptibility and promotes COVID-19 severityYuichi Mitsui, Tatsuya Suzuki, Kanako Kuniyoshi, et al.
Frontiers in Cardiovascular Medicine|December 6, 2021
Arterial and Venous Thrombosis Complicated in COVID-19: A Retrospective Single Center Analysis in JapanSeiya Oba, Tadashi Hosoya, Miki Amamiya, et al.
Pageof 16

Showing results (141-150 of 153) with videos related to

Sort By:
Pageof 16
Japanese Journal of Infectious Diseases|June 1, 2022
Association of SARS-CoV-2 RNA Copy Number with the COVID-19 Mortality Rate and Its Effect on the Predictive Performance of Mortality in Severe CasesTakahiro Mitsumura, Tsukasa Okamoto, Mizuho Tosaka, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 19, 2023
Safety and Efficacy of Long-Term Voclosporin Treatment for Lupus Nephritis in the Phase 3 AURORA 2 Clinical TrialAmit Saxena, Ellen M Ginzler, Keisha Gibson, et al.
Modern Rheumatology|December 11, 2013
A comparison of incidence and risk factors for serious adverse events in rheumatoid arthritis patients with etanercept or adalimumab in Korea and JapanSoo-Kyung Cho, Ryoko Sakai, Toshihiro Nanki, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2014
Autoantibodies to IgG/HLA class II complexes are associated with rheumatoid arthritis susceptibilityHui Jin, Noriko Arase, Kouyuki Hirayasu, et al.
Modern Rheumatology|August 22, 2020
Efficacy and safety of sodium RISedronate for glucocorticoid-induced OsTeoporosis with rheumaTOid arthritis (RISOTTO study): A multicentre, double-blind, randomized, placebo-controlled trialYuichiro Fujieda, Tetsuya Horita, Naoki Nishimoto, et al.
Arthritis Research & Therapy|April 17, 2015
Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registryRyoko Sakai, Soo-Kyung Cho, Toshihiro Nanki, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2026
LRBA organizes distinct vesicular trafficking systems in distal nephron segments for water and sodium conservationKanako Nagaoka, Fumiaki Ando, Tamami Fujiki, et al.
The Journal of Rheumatology|February 3, 2015
Assessment of risks of pulmonary infection during 12 months following immunosuppressive treatment for active connective tissue diseases: a large-scale prospective cohort studyHayato Yamazaki, Ryoko Sakai, Ryuji Koike, et al.
Immunity|July 13, 2023
Expression of the readthrough transcript CiDRE in alveolar macrophages boosts SARS-CoV-2 susceptibility and promotes COVID-19 severityYuichi Mitsui, Tatsuya Suzuki, Kanako Kuniyoshi, et al.
Frontiers in Cardiovascular Medicine|December 6, 2021
Arterial and Venous Thrombosis Complicated in COVID-19: A Retrospective Single Center Analysis in JapanSeiya Oba, Tadashi Hosoya, Miki Amamiya, et al.
Pageof 16